Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label on the page changes from v3.5.4 to v3.5.5. This reflects a metadata/version update and does not alter the visible content.
    Difference
    0.1%
    Check dated 2026-06-06T14:11:51.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision label (v3.5.4) replaces the previous v3.5.3, indicating a backend or display update without changing the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:49:33.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:21.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T20:46:57.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3; the previous label v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T17:23:58.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.